Page last updated: 2024-08-23

androstane-3,17-diol and MPTP Neurotoxicity Syndrome

androstane-3,17-diol has been researched along with MPTP Neurotoxicity Syndrome in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Al Sweidi, S; Bourque, M; Caruso, D; Di Paolo, T; Melcangi, RC; Morissette, M	1

Other Studies

1 other study(ies) available for androstane-3,17-diol and MPTP Neurotoxicity Syndrome

Article	Year
Neuroprotective Effect of Progesterone in MPTP-Treated Male Mice. Neuroendocrinology, 2016, Volume: 103, Issue:3-4 Topics: Androstane-3,17-diol; Animals; Autoradiography; Brain; Carbon Radioisotopes; Cocaine; Dihydrotestosterone; Disease Models, Animal; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Drug Administration Schedule; Male; Mice; Mice, Inbred C57BL; MPTP Poisoning; Neuroprotective Agents; Progesterone; Testosterone; Vesicular Monoamine Transport Proteins	2016

Article

Year

Neuroprotective Effect of Progesterone in MPTP-Treated Male Mice.

Neuroendocrinology, 2016, Volume: 103, Issue:3-4

Topics: Androstane-3,17-diol; Animals; Autoradiography; Brain; Carbon Radioisotopes; Cocaine; Dihydrotestosterone; Disease Models, Animal; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Drug Administration Schedule; Male; Mice; Mice, Inbred C57BL; MPTP Poisoning; Neuroprotective Agents; Progesterone; Testosterone; Vesicular Monoamine Transport Proteins

2016